BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23369168)

  • 1. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
    Maratea D; Fadda V; Trippoli S; Messori A
    Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
    Hadziyannis SJ
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1482. PubMed ID: 22582839
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
    Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
    J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
    Sadler MD; Lee SS
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
    Gao L; Trinh HN; Li J; Nguyen MH
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1339-40. PubMed ID: 24803254
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
    Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
    Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
    Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
    Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].
    MMW Fortschr Med; 2008 May; 150(21):43. PubMed ID: 18578068
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].
    Yang F; Wu XF; Wei N
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):65-6. PubMed ID: 20128975
    [No Abstract]   [Full Text] [Related]  

  • 11. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
    Reijnders JG; Janssen HL
    J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
    Bradshaw D; Danta M
    Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
    [No Abstract]   [Full Text] [Related]  

  • 13. [Improvement of health-related quality of life in chronic hepatitis B patients treated with entecavir or adefovir].
    Yu JH; Li Q; Yang X; Fan WB; Xie SS; Li WW; Liu L; Chen SJ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):305-6. PubMed ID: 21805739
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply.
    Gao L; Trinh HN; Li J; Nguyen MH
    Aliment Pharmacol Ther; 2014 May; 39(9):993. PubMed ID: 24689344
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
    Singal AK; Salameh H; Kuo YF; Fontana RJ
    Aliment Pharmacol Ther; 2013 Jul; 38(2):98-106. PubMed ID: 23713520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New option for successful therapy of chronic hepatitis B].
    Ortleb J
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
    [No Abstract]   [Full Text] [Related]  

  • 17. New nucleoside analogues for chronic hepatitis B.
    Schalm SW; Wolters LM; van Nunen AB; Niesters HG; de Man RA
    Acta Gastroenterol Belg; 2000; 63(2):191-3. PubMed ID: 10925461
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
    Mohamadnejad M
    Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chronic hepatitis B. High response rate in general practice].
    Einecke D
    MMW Fortschr Med; 2010 Jul; 152(28-30):22. PubMed ID: 20848981
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
    Asselah T; Marcellin P
    Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.